These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Preliminary report on the use of oral tacrolimus (FK506) in the treatment of complicated proximal small bowel and fistulizing Crohn's disease. Sandborn WJ Am J Gastroenterol; 1997 May; 92(5):876-9. PubMed ID: 9149205 [TBL] [Abstract][Full Text] [Related]
7. Oral tacrolimus (FK 506) in Crohn's disease complicated by fistulae of the perineum. Ierardi E; Principi M; Rendina M; Francavilla R; Ingrosso M; Pisani A; Amoruso A; Panella C; Francavilla A J Clin Gastroenterol; 2000 Mar; 30(2):200-2. PubMed ID: 10730928 [TBL] [Abstract][Full Text] [Related]
8. Oral tacrolimus for the treatment of refractory inflammatory bowel disease in the biologic era. Thin LW; Murray K; Lawrance IC Inflamm Bowel Dis; 2013 Jun; 19(7):1490-8. PubMed ID: 23615528 [TBL] [Abstract][Full Text] [Related]
10. Tacrolimus for the treatment of fistulas in patients with Crohn's disease: a randomized, placebo-controlled trial. Sandborn WJ; Present DH; Isaacs KL; Wolf DC; Greenberg E; Hanauer SB; Feagan BG; Mayer L; Johnson T; Galanko J; Martin C; Sandler RS Gastroenterology; 2003 Aug; 125(2):380-8. PubMed ID: 12891539 [TBL] [Abstract][Full Text] [Related]
11. Medium-term results of oral tacrolimus treatment in refractory inflammatory bowel disease. Ng SC; Arebi N; Kamm MA Inflamm Bowel Dis; 2007 Feb; 13(2):129-34. PubMed ID: 17206694 [TBL] [Abstract][Full Text] [Related]
12. Azathioprine is superior to budesonide in achieving and maintaining mucosal healing and histologic remission in steroid-dependent Crohn's disease. Mantzaris GJ; Christidou A; Sfakianakis M; Roussos A; Koilakou S; Petraki K; Polyzou P Inflamm Bowel Dis; 2009 Mar; 15(3):375-82. PubMed ID: 19009634 [TBL] [Abstract][Full Text] [Related]
13. The effect of tacrolimus (FK-506) on Japanese patients with refractory Crohn's disease. Tamaki H; Nakase H; Matsuura M; Inoue S; Mikami S; Ueno S; Uza N; Kitamura H; Kasahara K; Chiba T J Gastroenterol; 2008; 43(10):774-9. PubMed ID: 18958546 [TBL] [Abstract][Full Text] [Related]
14. Cyclosporine for induction of remission in Crohn's disease. McDonald JW; Feagan BG; Jewell D; Brynskov J; Stange EF; Macdonald JK Cochrane Database Syst Rev; 2005 Apr; (2):CD000297. PubMed ID: 15846602 [TBL] [Abstract][Full Text] [Related]
15. Systematic review: the role of tacrolimus in the management of Crohn's disease. McSharry K; Dalzell AM; Leiper K; El-Matary W Aliment Pharmacol Ther; 2011 Dec; 34(11-12):1282-94. PubMed ID: 21999607 [TBL] [Abstract][Full Text] [Related]
16. Topical tacrolimus may be effective in the treatment of oral and perineal Crohn's disease. Casson DH; Eltumi M; Tomlin S; Walker-Smith JA; Murch SH Gut; 2000 Sep; 47(3):436-40. PubMed ID: 10940284 [TBL] [Abstract][Full Text] [Related]
17. Performance of tacrolimus in hospitalized patients with steroid-refractory acute severe ulcerative colitis. Hoffmann P; Wehling C; Krisam J; Pfeiffenberger J; Belling N; Gauss A World J Gastroenterol; 2019 Apr; 25(13):1603-1617. PubMed ID: 30983820 [TBL] [Abstract][Full Text] [Related]
18. Conventional therapy for moderate to severe inflammatory bowel disease: A systematic literature review. Damião AOMC; de Azevedo MFC; Carlos AS; Wada MY; Silva TVM; Feitosa FC World J Gastroenterol; 2019 Mar; 25(9):1142-1157. PubMed ID: 30863001 [TBL] [Abstract][Full Text] [Related]
19. Topical tacrolimus 0.1% ointment for treatment of cutaneous Crohn's Disease. Rice SA; Woo PN; El-Omar E; Keenan RA; Ormerod AD BMC Res Notes; 2013 Jan; 6():19. PubMed ID: 23331739 [TBL] [Abstract][Full Text] [Related]